Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;55(9):7453-7462.
doi: 10.1007/s12035-018-0919-x. Epub 2018 Feb 9.

Fluoxetine Inhibits Natural Decay of Long-Term Memory via Akt/GSK-3β Signaling

Affiliations

Fluoxetine Inhibits Natural Decay of Long-Term Memory via Akt/GSK-3β Signaling

Jee Hyun Yi et al. Mol Neurobiol. 2018 Sep.

Abstract

Understanding the mechanisms underlying the natural decay of long-term memory can help us find means of extending the duration of long-term memory. However, the neurobiological processes involved in the decay of long-term memory are poorly understood. In the present study, we examined the effect of acute and chronic treatment of fluoxetine on natural decay of long-term memory and the possible mechanism. Late administration of fluoxetine prolonged the persistence of long-term memory in mice, as demonstrated by object location recognition and Barnes maze tests. Fluoxetine altered Akt/glycogen synthase kinase-3β (GSK-3β)/β-catenin signaling in the hippocampus. Late short- and long-term pharmacological inhibition of GSK-3β mimicked the effect of fluoxetine on memory persistence. Pharmacological inhibition of Akt blocked the effect of fluoxetine on memory persistence. Finally, late infusion of fluoxetine increased hippocampal long-term potentiation (LTP) and pharmacological inhibition of GSK-3β blocked the natural decline in LTP. These results demonstrate that GSK-3β might be a key molecule in memory decay process, and fluoxetine extends the period of long-term memory maintenance via Akt/GSK-3β signaling.

Keywords: Fluoxetine; GSK-3β; LTP maintenance; Memory decay.

PubMed Disclaimer

References

    1. Neuron. 2004 May 27;42(4):535-52 - PubMed
    1. Prog Neurobiol. 2016 Mar-May;138-140:1-18 - PubMed
    1. Nat Rev Cancer. 2002 Jul;2(7):489-501 - PubMed
    1. Sci Rep. 2016 Oct 19;6:35572 - PubMed
    1. Neuron. 2007 Mar 1;53(5):703-17 - PubMed

MeSH terms

Substances

LinkOut - more resources